PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 39 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,498 | +17.1% | 150,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $9,818 | +63.4% | 150,000 | 0.0% | 0.00% | – |
Q1 2023 | $6,008 | -99.6% | 150,000 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $1,540,545 | +1.8% | 150,000 | 0.0% | 0.05% | +32.4% |
Q3 2022 | $1,514,000 | +0.7% | 150,000 | 0.0% | 0.04% | +5.7% |
Q2 2022 | $1,503,000 | +0.1% | 150,000 | 0.0% | 0.04% | +2.9% |
Q1 2022 | $1,501,000 | +0.9% | 150,000 | 0.0% | 0.03% | -12.8% |
Q4 2021 | $1,487,000 | – | 150,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 163,538 | $1,636,000 | 0.09% |
Telemetry Investments, L.L.C. | 121,614 | $23,000 | 0.04% |
Radcliffe Capital Management, L.P. | 150,000 | $1,501,000 | 0.03% |
Q Global Advisors, LLC | 170,785 | $37,000 | 0.02% |
CANTOR FITZGERALD, L. P. | 363,548 | $79,000 | 0.01% |
Atalaya Capital Management LP | 225,000 | $50,000 | 0.01% |
MMCAP International Inc. SPC | 375,000 | $82,000 | 0.01% |
Bulldog Investors, LLP | 54,745 | $11,000 | 0.00% |
NEXPOINT ASSET MANAGEMENT, L.P. | 108,741 | $24,000 | 0.00% |
Context Capital Management, LLC | 200,000 | $44,000 | 0.00% |